Page last updated: 2024-10-19

niacinamide and Glomerulosclerosis, Focal Segmental

niacinamide has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izzedine, H1
Mangier, M1
Ory, V1
Zhang, SY1
Sendeyo, K1
Bouachi, K1
Audard, V1
PĂ©choux, C1
Soria, JC1
Massard, C1
Bahleda, R1
Bourry, E1
Khayat, D1
Baumelou, A1
Lang, P1
Ollero, M1
Pawlak, A1
Sahali, D1

Other Studies

1 other study available for niacinamide and Glomerulosclerosis, Focal Segmental

ArticleYear
Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
    Kidney international, 2014, Volume: 85, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Angiogenesis Inhibitors; Animals; Base Sequence;

2014